Trials / Unknown
UnknownNCT05549739
Evaluation of Respiratory Parameters and Functional Capacity in Coronary Artery Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Hacettepe University · Academic / Other
- Sex
- All
- Age
- 41 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate respiratory parameters and functional capacity in coronary artery patients.
Detailed description
Decreased pulmonary function as measured by forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), or peak expiratory flow (PEF) has been associated with an increased risk of cardiovascular mortality and morbidity. A low MIP value may generally indicate weak muscle strength and therefore be an indicator of general poor health. Respiratory muscle weakness and decreased respiratory muscle endurance affect exercise tolerance in individuals with chronic disease, including cardiovascular disease. Studies have supported the association of grip strength with frailty, physical activity, diabetes, functional limitation, nutritional status, metabolic syndrome, and mortality. The study will evaluate respiratory parameters and functional capacity in coronary artery patients.
Conditions
Timeline
- Start date
- 2022-09-23
- Primary completion
- 2022-11-01
- Completion
- 2022-11-01
- First posted
- 2022-09-22
- Last updated
- 2022-10-21
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05549739. Inclusion in this directory is not an endorsement.